UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049524
Receipt number R000056383
Scientific Title Verification study on the effects of intake of test foods on brain function.
Date of disclosure of the study information 2022/12/05
Last modified on 2023/10/05 14:40:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification study on the effects of intake of test foods on brain function.

Acronym

Verification study on the effects of intake of test foods on brain function.

Scientific Title

Verification study on the effects of intake of test foods on brain function.

Scientific Title:Acronym

Verification study on the effects of intake of test foods on brain function.

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effects on brain function of 12 consecutive weeks of consumption of the test food in adult male and female subjects who are aware of memory and attention decline.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cognitrax

Key secondary outcomes

Brain Age Meter ATMT (brain age [brain vitality, quickness, effective use of brain], stress intensity, brain traffic)
SF-36v2
POMS2
d-ROMs
BAP
Simple OSP (urinary 8-OHdG/creatinine corrected, PAO)
Oxidized LDL


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Daily intake of test food for 12 weeks

Interventions/Control_2

Daily intake of placebo (control food) for 12 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Healthy Japanese men and women who are 20 years of age or older at the time of consent.
2. Persons who are aware of memory or attention decline.
3. Persons who are suspected to have mild cognitive impairment (MCI) with a score of 24 to 29 on the MMSE screening test for dementia.
4. Persons who have signed a consent form prior to the start of the study upon full explanation of the purpose and content of the study.

Key exclusion criteria

1. Persons with a pre-existing or current condition of liver disease, renal disease, cerebrovascular disease, diabetes, dyslipidemia, hypertension, or other chronic disease.
2. Persons who are on treatment for a serious illness.
3. Persons engaged in brain training, puzzles, etc. for the purpose of brain training.
4. Persons with food allergies or those who may be allergic to the test food.
5. Persons who regularly use licensed drugs or quasi-drugs that may affect the study.
6. Persons who regularly use health foods that may affect the study.
7. Persons who are participating in a clinical trial or have participated in another clinical trial within 3 months from the date of obtaining consent.
8. Smokers, or non-smokers who have not smoked within 3 months prior to the start of the study.
9. Persons unable to maintain daily routines.
10. Pregnant, lactating, or wishing to become pregnant.
11. Persons who plan to participate in other examinations during the study.
12. Other subjects who are deemed inappropriate for this study by the investigator.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Shuichi
Middle name
Last name Segawa

Organization

Nissin York Co., Ltd.

Division name

Development Laboratories

Zip code

348-0005

Address

272, Tsutsumine, Kamimurakimi, Hanyu, Saitama, Japan

TEL

048-565-4686

Email

shuichi.segawa@nissin.com


Public contact

Name of contact person

1st name Ryoko
Middle name
Last name Koizumi

Organization

APO PLUS STATION CO., LTD.

Division name

CRO Department Clinical Operations Division

Zip code

103-0027

Address

2-14-1,Nihonbashi,Chuo-ku,Tokyo, Japan

TEL

03-6386-8809

Homepage URL


Email

food-contact@apoplus.co.jp


Sponsor or person

Institute

APO PLUS STATION CO., LTD.

Institute

Department

Personal name



Funding Source

Organization

Nissin York Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Watanabe Hospital

Address

1-5-16, Haneda, Ota ward, Tokyo, Japan

Tel

03-3741-0223

Email

wnb.cto@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人社団 渡辺病院


Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 11 Month 01 Day

Date of IRB

2022 Year 11 Month 08 Day

Anticipated trial start date

2022 Year 12 Month 06 Day

Last follow-up date

2023 Year 04 Month 23 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 11 Month 16 Day

Last modified on

2023 Year 10 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056383


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name